Levosimendan: Effective Heart Failure Treatment and Dosage Guide

Summary or Key Points

Levosimendan is a medication used to manage various types of heart failure, including acute and chronic heart failure, cardiogenic shock, and other heart-related conditions. It works by enhancing the heart’s ability to pump blood more effectively while reducing the strain on the heart. Levosimendan is typically administered in a hospital setting under close medical supervision. Always consult your healthcare provider before starting or adjusting any medication.

Names of Medication

US Brand Name: Simdax

Generic Name: Levosimendan

The generic name refers to the active ingredient in the medication. It is listed in parentheses next to the brand name.

Pharmacologic Category

Calcium Sensitizer

Inotropic Agent

Vasodilator

Levosimendan Dosage

Levosimendan is prescribed to treat several heart conditions. The dosage and frequency depend on the specific condition being managed. Always follow your doctor’s instructions carefully and consult them before making any changes to your dose. You can also schedule a telemedicine appointment with one of our providers for further guidance.

Heart Failure (Acute or Chronic)

Initial Dose: 6-12 mcg/kg administered over 10 minutes as a loading dose.

Maintenance Dose: 0.1 mcg/kg/min for up to 24 hours.

Cardiogenic Shock

Initial Dose: 6-12 mcg/kg administered over 10 minutes as a loading dose.

Maintenance Dose: 0.05-0.2 mcg/kg/min for up to 24 hours.

Myocardial Infarction (Heart Attack)

Initial Dose: 6-12 mcg/kg administered over 10 minutes as a loading dose.

Maintenance Dose: 0.1 mcg/kg/min for up to 24 hours.

Pulmonary Hypertension

Initial Dose: 6-12 mcg/kg administered over 10 minutes as a loading dose.

Maintenance Dose: 0.05-0.2 mcg/kg/min for up to 24 hours.

Congestive Heart Failure

Initial Dose: 6-12 mcg/kg administered over 10 minutes as a loading dose.

Maintenance Dose: 0.1 mcg/kg/min for up to 24 hours.

Left Ventricular Dysfunction

Initial Dose: 6-12 mcg/kg administered over 10 minutes as a loading dose.

Maintenance Dose: 0.1 mcg/kg/min for up to 24 hours.

Ischemic Heart Disease

Initial Dose: 6-12 mcg/kg administered over 10 minutes as a loading dose.

Maintenance Dose: 0.1 mcg/kg/min for up to 24 hours.

Cardiac Surgery Recovery

Initial Dose: 6-12 mcg/kg administered over 10 minutes as a loading dose.

Maintenance Dose: 0.05-0.2 mcg/kg/min for up to 24 hours.

Dosage Forms and Strengths

Solution for injection: 2.5 mg/mL

Administration Instructions for Levosimendan

Levosimendan is administered intravenously, typically in a hospital setting. It is delivered through an IV line directly into your bloodstream. The medication is usually infused over a period of 24 hours, depending on your condition and how your body responds to the treatment. Your healthcare provider will closely monitor your heart function, blood pressure, and other vital signs during the infusion. Do not attempt to self-administer this medication.

Levosimendan Side Effects and Adverse Reactions

Like all medications, Levosimendan may cause side effects. Some are more common, while others are rare but potentially serious. If you experience any side effects, contact your healthcare provider immediately. You can also schedule a telemedicine visit with one of our providers for further evaluation.

1. Headache (Common): Mild to moderate headaches may occur during treatment.
2. Hypotension (Common): Low blood pressure is a frequent side effect, which may cause dizziness or fainting.
3. Nausea (Common): Some patients may experience nausea during the infusion.
4. Arrhythmias (Less Common): Irregular heartbeats may occur and require immediate medical attention.
5. Chest Pain (Less Common): Some patients may experience chest discomfort or pain.
6. Allergic Reactions (Rare): Severe allergic reactions, including rash, swelling, or difficulty breathing, are rare but require immediate medical attention.

Contraindications for Levosimendan

A contraindication is a specific situation or condition where a particular treatment or medication should not be used because it may be harmful to the patient. For Levosimendan, certain conditions make it unsafe or inappropriate to use this medication. Below are the main contraindications for taking Levosimendan:

1. Severe kidney impairment: Levosimendan is primarily excreted through the kidneys. If your kidneys are not functioning well, the drug can accumulate in your system, leading to potential toxicity.
2. Severe liver impairment: The liver plays a crucial role in processing medications. If you have severe liver problems, Levosimendan may not be metabolized properly, increasing the risk of side effects.
3. Severe low blood pressure (hypotension): Levosimendan can lower blood pressure. If you already have low blood pressure, taking this medication could cause it to drop to dangerous levels, leading to dizziness, fainting, or even shock.
4. History of ventricular arrhythmias: Levosimendan can increase the risk of abnormal heart rhythms, especially in patients with a history of ventricular arrhythmias (irregular heartbeats originating in the lower chambers of the heart).
5. Allergy to Levosimendan: If you have had an allergic reaction to Levosimendan or any of its components in the past, you should not take this medication.

Drug to Drug Interactions

Levosimendan can interact with various medications, potentially altering its effectiveness or increasing the likelihood of side effects. Below are some drugs that may interact with Levosimendan:

Beta-blockers (e.g., Metoprolol, Atenolol): These medications slow the heart rate and lower blood pressure, which may counteract the effects of Levosimendan, a calcium sensitizer used in heart failure management.

Calcium channel blockers (e.g., Amlodipine, Diltiazem): These drugs also reduce blood pressure and may increase the risk of hypotension when taken with Levosimendan.

Diuretics (e.g., Furosemide, Hydrochlorothiazide): Diuretics help lower blood pressure, and when combined with Levosimendan, the risk of low blood pressure (hypotension) may be heightened.

Antiarrhythmic medications (e.g., Amiodarone, Digoxin): These drugs are used to treat irregular heartbeats, and combining them with Levosimendan may increase the risk of arrhythmias.

Vasodilators (e.g., Nitroglycerin, Hydralazine): These medications widen blood vessels and lower blood pressure, which could amplify Levosimendan’s blood pressure-lowering effects.

Levosimendan in Pregnancy

Is it safe to take Levosimendan when pregnant?

There is limited information on the safety of Levosimendan during pregnancy. While animal studies have shown some adverse effects on fetal development, there is not enough human research to confirm these findings. As a result, Levosimendan should only be used during pregnancy if the potential benefits outweigh the risks. If you are pregnant or planning to become pregnant, it is essential to consult your healthcare provider before starting Levosimendan. Our telemedicine providers are available to discuss your treatment options and help you make an informed decision.

Levosimendan while Breastfeeding

Is it safe to take Levosimendan while breastfeeding?

There is insufficient data on whether Levosimendan passes into breast milk or its potential effects on a nursing infant. Due to this lack of information, it is generally recommended to avoid using Levosimendan while breastfeeding unless absolutely necessary. If you are breastfeeding and considering Levosimendan, consult your healthcare provider. You can also schedule a telemedicine appointment with one of our providers to explore safer alternatives.

Estimated Cost of Levosimendan

The estimated cost of a 30-day supply of Levosimendan without insurance can vary. Based on current pricing, using a GoodRX coupon, the cost typically ranges from $1,500 to $2,000. Prices may differ depending on the pharmacy and location, so it’s a good idea to check with your pharmacy for the most accurate pricing.

Possible Alternatives to Levosimendan

Depending on your condition, alternative treatments or lifestyle changes may help manage your symptoms. Always consult your healthcare provider before making any changes to your treatment plan. Below are some alternatives for conditions commonly treated with Levosimendan:

1. Heart failure: Alternatives include ACE inhibitors (e.g., Lisinopril), beta-blockers (e.g., Carvedilol), and lifestyle changes such as reducing sodium intake and engaging in regular physical activity.
2. Acute decompensated heart failure: Diuretics (e.g., Furosemide) and vasodilators (e.g., Nitroglycerin) are often used. In some cases, mechanical support devices like intra-aortic balloon pumps may be considered.
3. Chronic heart failure: Medications like ARBs (e.g., Losartan) and lifestyle changes such as weight management and regular exercise can be beneficial.
4. Cardiogenic shock: Treatment often includes inotropes (e.g., Dobutamine) and mechanical support devices. Early intervention is crucial.
5. Myocardial infarction (heart attack): Alternatives include antiplatelet drugs (e.g., Aspirin), beta-blockers, and lifestyle changes such as quitting smoking and adopting a heart-healthy diet.
6. Pulmonary hypertension: Medications like endothelin receptor antagonists (e.g., Bosentan) and phosphodiesterase inhibitors (e.g., Sildenafil) may be used.
7. Congestive heart failure: Diuretics, ACE inhibitors, and lifestyle changes such as reducing fluid intake and monitoring weight can help manage symptoms.
8. Left ventricular dysfunction: Beta-blockers and ACE inhibitors are commonly prescribed, along with lifestyle changes like reducing alcohol consumption.
9. Ischemic heart disease: Statins (e.g., Atorvastatin) and lifestyle changes such as increasing physical activity and eating a balanced diet can help manage this condition.
10. Cardiac surgery recovery: Medications like beta-blockers and anticoagulants (e.g., Warfarin) may be prescribed. Cardiac rehabilitation programs focusing on exercise and lifestyle changes can also aid recovery.

Recent Updates on Levosimendan Research

Recent studies have explored Levosimendan’s potential benefits beyond heart failure. Some research suggests it may improve outcomes in patients undergoing cardiac surgery by reducing the risk of postoperative complications, such as low cardiac output syndrome. Additionally, ongoing studies are investigating its use in treating pulmonary hypertension and right ventricular failure. However, more research is needed to confirm these findings and expand its use in clinical practice.

If you have any questions about Levosimendan or are considering it as part of your treatment plan, our telemedicine providers are here to help. Schedule a virtual consultation today to discuss your options.

James Kingsley

Learn More